Success Metrics

Clinical Success Rate
42.9%

Based on 3 completed trials

Completion Rate
43%(3/7)
Active Trials
10(48%)
Results Posted
233%(7 trials)
Terminated
4(19%)

Phase Distribution

Ph not_applicable
4
19%
Ph phase_3
5
24%
Ph phase_2
5
24%
Ph phase_1
6
29%

Phase Distribution

6

Early Stage

5

Mid Stage

5

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
6(30.0%)
Phase 2Efficacy & side effects
5(25.0%)
Phase 3Large-scale testing
5(25.0%)
N/ANon-phased studies
4(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

37.5%

3 of 8 finished

Non-Completion Rate

62.5%

5 ended early

Currently Active

10

trials recruiting

Total Trials

21

all time

Status Distribution
Active(10)
Completed(3)
Terminated(5)
Other(3)

Detailed Status

Recruiting5
Active, not recruiting5
Terminated4
unknown3
Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
10
Success Rate
42.9%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (30.0%)
Phase 25 (25.0%)
Phase 35 (25.0%)
N/A4 (20.0%)

Trials by Status

terminated419%
withdrawn15%
recruiting524%
unknown314%
completed314%
active_not_recruiting524%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT04403620Phase 1

HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer

Active Not Recruiting
NCT05600842

De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx

Recruiting
NCT06682442Not Applicable

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Recruiting
NCT04288375Phase 2

Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

Active Not Recruiting
NCT07340515Phase 3

Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial

Recruiting
NCT04124198Not Applicable

Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma

Active Not Recruiting
NCT03137771Phase 2

Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Active Not Recruiting
NCT06056310Phase 1

Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)

Terminated
NCT02984410Not Applicable

Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma

Active Not Recruiting
NCT06250972Phase 3

Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer

Recruiting
NCT06501911Phase 1

A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma

Withdrawn
NCT04397679Phase 1

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

Terminated
NCT00321698Phase 1

Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer

Terminated
NCT06011291Phase 1

A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer

Unknown
NCT01084083Phase 2

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Completed
NCT05527470Phase 3

Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Recruiting
NCT02308488Not Applicable

Study of Prone Accelerated Breast And Nodal IMRT

Completed
NCT04529850Phase 2

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Completed
NCT01687413Phase 3

Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer

Terminated
NCT03612219Phase 2

Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma

Unknown

Drug Details

Intervention Type
RADIATION
Total Trials
21